Tag Archives: COVID-19 patients

disease, Health

SARS-CoV-2 is that its effects on individuals differ

Leave a comment

One thing that we know about SARS-CoV-2 is that its effects on individuals differ. This coronavirus continues to bring new shocks as the pandemic rolls on.

A team of researchers and physicians has now documented the case of one woman with leukemia who had no signs of COVID-19, but she was already shedding infectious SARS-CoV-2 particles 70 days after her first complimentary examination.

This outcome is much longer than prior reports of hospitalized adults observed shedding contagious SARS-CoV-2 virus up to 20 days after their diagnosis of COVID-19, plus other reports of individuals shedding genetic material from the virus up to 63 days after the first appearance of their symptoms.


Reference
Startling Case Study Finds Asymptomatic COVID-19 Carrier …. https://monkeyviral.com/startling-case-study-finds-asymptomatic-covid-19-carrier-who-shed-virus-for-70-days/

disease, Health

Some Covid-19 patients experience a long-lasting skin issues following the infection

Leave a comment

Some Covid-19 patients experience a long-lasting skin issues following the infection, researchers from Massachusetts General Hospital are finding, including rashes, hives, and “Covid toes,” underpinning previous, limited research about a collection of new symptoms connected with Covid-19 and yet another troubling sign that for a few the herpes virus could have an enduring impact.

The research unearthed that some patients reported skin issues for as much as five months, though an average of patients only experiences observable symptoms for 12 days.

This set of Covid-19 symptoms contributes to mounting evidence that, for a few, the illness may be a long haul — lots of people are now calling this the “long Covid.”

Symptoms varied in severity, though generally mild, researchers said, you need to include rashes, hives, and chilblains, the very last of that your researchers have termed “Covid toes.”

The findings that have been presented in the EADV Virtual congress Thursday and result from studying the info of nearly 1,000 long Covid cases in 39 different countries may help scientists comprehend the body’s inflammatory reaction to Covid-19 infection.
Reference
‘Covid Toes,’ Rashes, And Hives: New Research Underpins …. https://www.forbes.com/sites/roberthart/2020/10/29/covid-toes-rashes-and-hives-new-research-underpins-covid-19s-long-term-skin-impact/

disease, drugs, Health, medications, Pharmaceuticals

Regeneron Pharmaceuticals has paused critically ill COVID-19 patients’ enrollment

Leave a comment

Regeneron Pharmaceuticals has paused critically ill COVID-19 patients’ enrollment with its trial studying the antibody cocktail treatment, which was fond of President Trump earlier this month. The choice is because of potential safety concerns.
The drugmaker on Friday said it was suspending the enrollment of hospitalized #COVID-19 patients requiring high-flow oxygen or mechanical ventilation after an unbiased monitoring committee observed “a potential safety signal and an unfavorable risk/benefit profile at the moment.”

The enrollment of individuals in this category should be on hold, pending the collection and evaluation of additional data.

Trials continue to test the antibody cocktail in hospitalized patients necessitating little if any extra oxygen. Other trials involving mild or moderately ill patients also can move ahead.

The drug has revealed encouraging outcomes. Regeneron on Wednesday said early data confirmed the therapy lowered COVID-19 related medical visits by 57 percent.

Regeneron earlier this month asked the foodstuff and Drug Administration for emergency approval and said it could make doses accessible to the American people free of charge. The drugmaker said it might have sufficient doses for 300,000 people when looking at the coming months.

Reference

Regeneron stops enrolling critically ill COVID-19 patients …. https://news.immitate.com/2020/10/30/regeneron-stops-enrolling-critically-ill-covid-19-patients-for-antibody-drug-trial-thehill-the-hill/.